When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like.
To learn more about how CNN protects listener privacy, visit cnn.com/privacy
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Breaking Up (and Making Up) with Your Phone
How Much Screen Time is Too Much?
How to Raise Kids in the Digital Age
Season Six: A Personal Journey for Sanjay
The Mystery of the Teenage Brain
Sanjay investigates “Havana Syndrome” Pt. 2
Sanjay investigates “Havana Syndrome” Pt. 1
What Promise Do Psychedelics Hold As Therapeutics?
When You Hear Colors and Taste Shapes
The Power of Sound
Smelling Your Way To Love
The Science Behind a Good Night's Sleep
Food for Thought, Literally
Living a Sensory-Informed Life
Expanding Your Senses
Pain is a Four-Letter Word
Finding Your Quiet Space
How Do You Recognize a Face?
Sniffing Out the Cause of Smell Loss
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Newscast
Consider This from NPR
What’s That Rash?
The Coronavirus Podcast
Up First